Abiopharma

IREN Closes $3.65bn Investment-Grade GPU Financing

NEURONES : Déclaration des transactions sur actions propres (période du 25 au 29 mai 2026)

NEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)

SAIC Announces First Quarter of Fiscal Year 2027 Results

Opening of Trading On June 02 2026- AFI PROP P6

Net Asset Value(s)

Immediate Report of a Meeting

Citius Oncology - Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies

Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID

Bruker - Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology